BLASTIC PRESENTATION OF CHRONIC MYELOGENOUS LEUKEMIA WITH INV(16)AND COEXPRESSION OF BOTH P210BCR/ABL1 AND P190BCR/ABL1 TRANSCRIPTS

被引：0
|
作者：
Zaldini, Piera [1 ]
Albertazzi, Laura [1 ]
Bellesia, Enrica [1 ]
Bonanno, Orsola [1 ]
Castellini, Gabriella [1 ]
Facchini, Luca [1 ]
Longo, Rosina [1 ]
Rinaldini, Monia [1 ]
Vecchia, Luigi [1 ]
机构：
[1] IRCCS Santa Maria Nuova Hosp, Reggio Emilia, Italy
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2016年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] New practice of BCR::ABL1 standardization system based on p210 and p190 BCR::ABL1 reference materials
    Ma, Yu
    Han, Yanxi
    Diao, Zhenli
    Chen, Yuqing
    Huang, Tao
    Feng, Lei
    Jiang, Jian
    Zhang, Yuanfeng
    Li, Jinming
    Zhang, Rui
    CLINICA CHIMICA ACTA, 2025, 565
  • [2] p210BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)
    Hai-ping Dai
    Yong-quan Xue
    Li–li Wu
    Jin-lan Pan
    Yan-lei Gong
    Ya-fang Wu
    Jun Zhang
    De-pei Wu
    Su-ning Chen
    International Journal of Hematology, 2012, 96 : 814 - 817
  • [3] p210BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16)
    Dai, Hai-ping
    Xue, Yong-quan
    Wu, Li-li
    Pan, Jin-lan
    Gong, Yan-lei
    Wu, Ya-fang
    Zhang, Jun
    Wu, De-pei
    Chen, Su-ning
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (06) : 814 - 817
  • [4] DIFFERENCES IN TYROSINE PHOSPHORYLATED PROTEINS BETWEEN CELLS EXPRESSING P210BCR/ABL AND P190BCR/ABL
    NISHIMURA, J
    SHIBATA, K
    SADAMURA, S
    TAKAHIRA, H
    HIRATA, J
    UMEMURA, T
    NAWATA, H
    OKAMURA, J
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1992, 55 (03) : 227 - 233
  • [5] Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts
    Yamaguchi, H
    Inokuchi, K
    Shinohara, T
    Dan, K
    CANCER GENETICS AND CYTOGENETICS, 1998, 102 (01) : 74 - 77
  • [6] Downstream effectors of activated ABL kinase in hematopoietic cells mediated by p210BCR/ABL, p190BCR/ABL, and TEL/ABL.
    Okuda, K
    Golub, T
    Gilliland, DG
    Griffin, JD
    BLOOD, 1995, 86 (10) : 1735 - 1735
  • [7] p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell Lines
    Okuda, K
    Golub, TR
    Gilliland, DG
    Griffin, JD
    ONCOGENE, 1996, 13 (06) : 1147 - 1152
  • [8] 2 BCR/ABL FUSION GENE-PRODUCTS, P210BCR/ABL AND P190BCR/ABL, ARE EQUALLY SENSITIVE TO THE PROTEIN TYROSINE PHOSPHATASE OF MATURE GRANULOCYTES
    NISHIMURA, J
    OKAMURA, J
    SHIBATA, K
    TAKAHIRA, H
    YUFU, Y
    KATO, S
    HIRATA, J
    UMEMURA, T
    NAWATA, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1991, 54 (06) : 471 - 478
  • [9] Prevalence of the BCR/ABL1 transcripts in Mexican patients with chronic myelogenus leukemia
    Pablo Meza-Espinoza, Juan
    Gutierrez-Angulo, Melva
    Vazquez-Cardenas, Alejandra
    Luis Delgado-Lamas, Jose
    Amparo Esparza-Flores, Maria
    Ramon Gonzalez-Garcia, Juan
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2007, 59 (05): : 338 - 341
  • [10] ABL001 (asciminib) Efficiently Targets Transplantable BCR::ABL1 Lymphoid Blast Crisis in the Scl-Tta-p210-BCR::ABL1 Mouse Model
    Chatain, Nicolas
    Baumeister, Julian
    de Toledo, Marcelo Szymanski
    Wong, Dickson W. L.
    Gupta, Siddharth
    Pannen, Kristina
    Junge, Baerbel
    Bruemmendorf, Tim H.
    Boor, Peter
    Koschmieder, Steffen
    BLOOD, 2023, 142
12345